CONCERTA® For the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Treatment of attention deficit hyperactivity disorder (ADHD) in a patient diagnosed between the ages of 6 and 18 years inclusive, who has demonstrated a response to immediate release methylphenidate hydrochloride with no emergence of serious adverse events, and who requires continuous coverage over 12 hours
S8 – Controlled Drug
Please consult the PBS schedule for full information, available at www.pbs.gov.au
CONCERTA® is administered orally once daily and should be taken in the morning. CONCERTA® must be swallowed whole with the aid of liquids, and must not be chewed, divided or crushed. CONCERTA® may be administered with or without food. Treatment should be started on the lowest possible dose.
For further information please consult Dosage and Administration in Product Information